Less Ads, More Data, More Tools Register for FREE

Pin to quick picksXaar Regulatory News (XAR)

Share Price Information for Xaar (XAR)

Share Price is delayed by 15 minutes
Get Live Data
138.00    -2.00 (-1.43%)
Bid:
136.00
Ask:
144.50
Spread: 8.50 (6.25%)
Market Cap: £108.29m
XAR Live PriceLast checked at - London Stock Exchange

Intraday Xaar Share Chart

Control change for partner

29 Jan 2008 07:01

Xaar PLC29 January 2008 FOR IMMEDIATE RELEASE 29 January 2008 Xaar plc PURCHASE OF A MAJORITY HOLDING IN XENNIA TECHNOLOGY LTD. BY ROYAL TEN CATE NV Xaar plc ("Xaar"), the inkjet printing technology group headquartered in Cambridge is pleased to announce that Xennia Technology Ltd. ("Xennia"), in which Xaar has a minority interest, has entered into an agreement with Royal Ten Cate nv ("Ten Cate") under which Ten Cate will purchase a 75% stake in the company from the founder and other management. Xaar will retain its minority investment in Xennia and will partner with Ten Cate in its development of inkjetfor the specialist textile and materials markets. Based in the Netherlands, Ten Cate is a specialist textile and materials group listed on the NYSE Euronext Amsterdam stock exchange (stock code:KTC). Inkjet is an emerging technology in the printing of textiles and in the application of specialist coatings and other related production processes for the textile market. Xaar has enjoyed a collaborative relationship with Xennia since June 2004, strengthened in September 2005 when Xaar acquired a minority interest in the company. Commenting on the agreement, Xaar's Chief Executive, Ian Dinwoodie, said "I am pleased that Xennia has strengthened its position for the future through what is an innovative and collaborative agreement with Ten Cate. We already work withTen Cate under an EU Framework project and we look forward to working more closely with them in the future and to establishing inkjet as a key production process for the textile and specialist materials market." Ends Contacts Xaar plc: 01223-423663Ian Dinwoodie, Chief Executive www.xaar.co.ukNigel Berry, Group Finance Director & DeputyChief Executive Bankside Consultants:Steve Liebmann or Simon Bloomfield 020-7367-8883 / 07802-888159 This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
3rd Feb 20254:15 pmRNSTotal Voting Rights
22nd Jan 202512:30 pmRNSBlock listing Interim Review
21st Jan 20253:00 pmRNSHolding(s) in Company
15th Jan 20257:00 amRNSTrading update & notification of full year results
15th Jan 20257:00 amRNSAppointment of Chief Financial Officer
11th Dec 202410:30 amRNS2024 Full Year Trading Update
4th Dec 202410:45 amRNSUpdate statement on 2024 AGM voting results
3rd Dec 202410:50 amRNSTotal Voting Rights
20th Nov 20247:00 amRNSBoard changes
1st Nov 202412:00 pmRNSTotal Voting Rights
1st Oct 202411:30 amRNSTotal Voting Rights
18th Sep 20247:00 amRNSInterim Results
2nd Sep 20241:45 pmRNSTotal Voting Rights
2nd Aug 20242:30 pmRNSHolding(s) in Company
1st Aug 202411:15 amRNSTotal Voting Rights
30th Jul 20247:00 amRNSNOTICE OF RESULTS AND UPDATE ON TRADING
3rd Jul 202411:45 amRNSBlock listing Interim Review
2nd Jul 20242:00 pmRNSTotal Voting Rights
28th Jun 202410:00 amRNSDirector Declaration
3rd Jun 20242:45 pmRNSTotal Voting Rights
30th May 202412:00 pmRNSBoard changes
29th May 20241:45 pmRNSResult of AGM
29th May 20249:30 amRNSHolding(s) in Company
21st May 20249:30 amRNSDirector/PDMR Shareholding
20th May 20244:30 pmRNSDirector/PDMR Shareholding
13th May 20249:42 amRNSHolding(s) in Company
1st May 20244:15 pmRNSTotal Voting Rights
30th Apr 20244:30 pmRNSDirector/PDMR Shareholding
22nd Apr 202410:51 amRNSAnnual Financial Report
2nd Apr 202412:00 pmRNSTotal Voting Rights
1st Mar 202410:15 amRNSTotal Voting Rights
26th Feb 20249:00 amRNSHolding(s) in Company
23rd Feb 202410:30 amRNSBoard Change
1st Feb 20241:32 pmRNSTotal Voting Rights
29th Jan 202412:04 pmRNSHolding(s) in Company
12th Jan 20243:15 pmRNSBlock listing Interim Review
12th Jan 20247:00 amRNSNotification of Results & Full year Guidance
8th Jan 202412:36 pmRNSTotal Voting Rights
12th Dec 20239:00 amRNSNotification of Transactions of Directors & PDMRs
11th Dec 20233:00 pmRNSNotification of Transactions of Directors & PDMRs
1st Dec 202311:00 amRNSTotal Voting Rights
1st Dec 202310:00 amRNSDirector Declaration
29th Nov 20237:00 amRNSTrading Update
17th Nov 20234:07 pmRNSHolding(s) in Company
9th Nov 20231:53 pmRNSDirector/PDMR Shareholding
3rd Nov 202310:52 amRNSHolding(s) in Company
1st Nov 20234:03 pmRNSTotal Voting Rights
30th Oct 20237:00 amRNSBoard Changes
2nd Oct 202311:45 amRNSTotal Voting Rights
21st Sep 20233:16 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.